文献速递其他结缔组织病

通过双能X线吸收法和握力计评估的肌少症:炎症性肌病中损害、残疾和肌因子失衡的潜在标志物

Sarcopenia assessed by DXA and hand-grip dynamometer: a potential marker of damage, disability and myokines imbalance in inflammatory myopathies.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

该前瞻性研究纳入40例病程≥12个月、疾病活动度低或无活动≥6个月的成人炎症性肌病患者和30名健康对照,用全身双能X线吸收法和握力计诊断肌少症(EWGSOP2标准)。患者肌量和握力分别较志愿者降低10%和30%,肌量和握力与肌肉力量、功能、患者报告残疾、损害评分及多种肌因子水平相关;7例(17.5%)患者存在肌少症。作者结论认为双能X线吸收法和握力计是评估炎症性肌病损害的有用工具,鸢尾素和骨连接素可能参与损害发病机制。

要点

  • 炎症性肌病患者肌量和握力分别较健康志愿者降低10%和30%,且个体间离散度大。
  • 7例(17.5%)炎症性肌病患者符合EWGSOP2肌少症标准,其损害、功能受损、残疾和严重肌病史最重。
  • 鸢尾素和骨连接素水平降低与肌少症相关(曲线下面积分别为0.71和0.80)。

核心结论

  • 双能X线吸收法和握力计是评估炎症性肌病损害的有用工具,鸢尾素和骨连接素可能在炎症性肌病损害发病机制中发挥作用。

研究设计与样本

  • 前瞻性纳入40例病程≥12个月、疾病活动度低或无活动≥6个月的成人炎症性肌病患者,并纳入30名年龄和性别匹配的健康志愿者作为对照。
  • 采用全身双能X线吸收法和握力计测量肌肉量、握力,并按EWGSOP2标准诊断肌少症。
  • 评估12块肌肉力量、功能测试、患者报告残疾、IMACS损害评分与病史的关系,并检测血清中潜在分子介质水平。

主要发现

  • 双能X线吸收法和握力测量耗时≤20分钟。
  • 炎症性肌病患者肌肉量较志愿者降低10%(四分位间距-24.3%至+7.8%),握力较志愿者降低30%(四分位间距-51.3%至-18.9%)。
  • 肌肉量和握力与14块肌肉力量(徒手肌力测试和手持测力计)、肢体/呼吸/吞咽功能、患者报告残疾、肌肉及肌肉外领域损害的范围和严重程度、以及多种肌因子血液水平呈非冗余相关(r最高达0.6,P=0.0001)。
  • 7例(17.5%)炎症性肌病患者存在肌少症,其损害最重、功能受损、残疾且有严重肌病史。
  • 鸢尾素和骨连接素水平降低与肌少症相关(曲线下面积分别为0.71和0.80)。

关键数值与推荐

  • 肌少症采用EWGSOP2标准诊断。
  • 炎症性肌病患者肌肉量较志愿者降低10%,握力较志愿者降低30%。
  • 鸢尾素和骨连接素水平降低与肌少症相关,曲线下面积分别为0.71和0.80。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the ability of dual-energy X-ray absorptiometry (DXA) and hand-grip dynamometer to measure damage in inflammatory myopathies (IM). METHODS: Forty adult IM patients with a disease duration ≥12 months, low or no disease activity for ≥6 months, were prospectively enrolled. Thirty healthy age and sex-matched volunteers were enrolled as controls. Whole-body DXA and hand-grip dynamometer were used to measure muscle mass, grip strength and diagnose sarcopenia (EWGSOP2 criteria). Relationships between the results of strength in 12 muscles, functional tests, patient-reported disability, IMACS damage score, and history of the disease were assessed. The serum levels of potential molecular actors in the damage were measured. RESULTS: DXA and grip strength measurements took ≤20 min. Both muscle mass and grip strength were decreased in IM patients vs volunteers (-10% and -30%, respectively) with a dispersion that varied widely (interquartile range -24.3% to +7.8% and -51.3% to -18.9%, respectively). Muscle mass and grip strength were non-redundantly correlated (r up to 0.6, P = 0.0001) with strength in 14 muscles (manual muscle test and hand-held dynamometer), functions (of limbs, respiratory and deglutition muscles), patient-reported disability, damage (extension and severity in muscular and extra-muscular domains) and blood levels of several myokines. Seven IM patients (17.5%) were sarcopenic. They had the worst damage, impaired functions, disability and history of severe myopathy. Decreased irisin and osteonectin levels were associated with sarcopenia (area under the curve 0.71 and 0.80, respectively). CONCLUSION: DXA and hand-grip dynamometer are useful tools to assess damage in IM. Irisin and osteonectin may play a role in IM damage pathogenesis.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Giannini M, Charles AL, Evrard C, et al. Sarcopenia assessed by DXA and hand-grip dynamometer: a potential marker of damage, disability and myokines imbalance in inflammatory myopathies. Rheumatology (Oxford). 2024. PMID: 38544289. doi:10.1093/rheumatology/keae207

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。